Clinical Trial
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
ClinicalTrials.gov5/6/2026ยท05/06/26๐ Asia
Summary
Peking University People's Hospital plans a 216-patient study of transcutaneous auricular vagus nerve stimulation, with sham stimulation as the comparator, for joint and muscle pain caused by aromatase inhibitors in breast cancer. The sponsor's title also mentions immunoregulatory T cells. The registry lists it as not yet recruiting, with completion estimated for 2029.
Why it matters
It applies taVNS to cancer-treatment side effects. The T-cell element in the title is not described as an arm in the registry data I read, so treat the combination claim with caution.
#Aromatase Inhibitor Pain#Breast Cancer#VNS#Neurostimulation#Asia
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items โ updated daily.
Start free trialAlready a member? Sign in